SARS-CoV-2 hybrid immunity: silver bullet or silver lining? | Nat Rev Immunol;22(10): 591-592, 2022 10. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

SARS-CoV-2 hybrid immunity: silver bullet or silver lining?

Suryawanshi, Rahul; Ott, Melanie.

Suryawanshi R; Gladstone Institutes, San Francisco, CA, USA.
Ott M; Gladstone Institutes, San Francisco, CA, USA. melanie.ott@gladstone.ucsf.edu.

Nat Rev Immunol ; 22(10): 591-592, 2022 10.

Article in English | MEDLINE | ID: covidwho-1984399

Subject(s)

COVID-19; SARS-CoV-2; Humans

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: S41577-022-00771-8

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: S41577-022-00771-8